Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-29 @ 1:58 AM
Study NCT ID:
NCT01271803
Status:
COMPLETED
Last Update Posted:
2019-07-29
First Post:
2011-01-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2013-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-05
First Submit QC Date:
None
Study First Post Date:
2011-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-11
Results First Submit QC Date:
None
Results First Post Date:
2016-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-26
Last Update Post Date:
2019-07-29
Last Update Post Date Type:
ACTUAL